The Lancet Infectious Diseases· Rea Grace Maamari, Tom G S Williams, Cindy Zheng, Berkin Hack, Oliver Tomkins, Prijay Bakrania, Rajeni Thangarajah, Inès Ringue, Nathaniel Storey, Julianne R Brown, Sofia Morfopoulou, Caroline Solas, Nadège Néant, Jake Daddiego, Valentine Okonkwo, Julie Chandra, Tommy Rampling, Catherine F Houlihan, Judith Breuer, Iain Milligan, Sam Douthwaite, Matthew Streetly, Devan Vaghela·· 4 小时前AI 评分31
病例讨论：骨髓瘤患者接受双特异性抗体 teclistamab 治疗后发生淋巴细胞脉络丛脑膜炎病毒脑膜脑炎的联合抗病毒治疗
[Grand Round] Combination antiviral treatment for a patient with lymphocytic choriomeningitis virus meningoencephalitis associated with bispecific antibody teclistamab therapy for myeloma
AI 导读
一名接受 teclistamab 治疗的复发性多发性骨髓瘤患者发生淋巴细胞脉络丛脑膜炎病毒（LCMV）脑膜脑炎。LCMV 是罕见的脑膜脑炎病因，在免疫功能正常者中感染具有自限性，但在免疫功能低下者中可引起重症；正文未提供联合抗病毒治疗方案或疗效。
来源：The Lancet Infectious Diseases · thelancet.com